Explore data for a JAK inhibitor in patients with active PsA who have had an inadequate response or intolerance to one or more bDMARDs. Through this piece, learn more about the mechanism of action,...
Treatment goals can be challenging for those with RA who are bDMARD-IR. Hear Dr. Tesser’s approach and learn about SELECT-BEYOND, where a JAK inhibitor was assessed in such patients.
Many patients with PsA cannot achieve comprehensive control of their symptoms, despite a variety of available treatments. Learn more about an available JAK inhibitor along with findings from the two phase 3...
An existing medication was recently approved by the US Food and Drug Administration for use in individuals with active psoriatic arthritis. Learn more about the study data leading to this expanded...
Axial spondyloarthritis (axSpA) diseases, consisting of radiographic axSpA (ankylosing spondylitis) and non-radiographic axSpA, are inflammatory arthritides that mainly affect the axial skeleton,...
